Grant Yonehiro
Chief Operating Officer · Bolt Biotherapeutics, Inc.
- 2025
- Sep 21, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Grant Yonehiro files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William P. Quinn - $62K in BOLT purchases and sales in the last 12 months
- Sarah Nemec - $29K in BOLT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Grant Yonehiro?
Grant Yonehiro is a corporate insider, tracked as Chief Operating Officer of Bolt Biotherapeutics, Inc. (BOLT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Grant Yonehiro submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Grant Yonehiro been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($44K) across all tracked filings.
